Mometasone
NASONEX
Pronunciation: moe-MET-a-soen
“Nose is next (for) Mommy’s taser”
What it isGlucocorticoid-receptor agonist used for asthma, allergic rhinitis, and inflammatory dermatoses.
Why this oneHigh first-pass metabolism gives strong local effect with little systemic exposure, which suits long-term intranasal use.
What limits itOral candidiasis when inhaled; epistaxis intranasally. Topical use carries the usual atrophy risk.
FDA-approved for
- asthma/rhinitis (1997)
FDA label
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Nasal allergy symptoms | ≥12 yr | 2 sprays/nostril QD | ||
| Nasal allergy symptoms | 2–11 yr | 1 spray/nostril QD |
Renal Undefined
Hepatic Undefined
Instructions
- Prime the bottle before first use; shake well before each use.
- Use only once a day; do not use more than directed.
- Children 2–11: use under adult supervision, for the shortest time needed; consult a doctor if used more than two months a year.
- Do not use in children under 2 years.
Available strengths
- nasal spray 50 mcg/spray
- powder 0.11, 0.22 mg/inh
- sol 1 mg/mL
- cream 0.1 %
- inhaler 50, 100, 200 mcg/inh
- lotion 0.1 %
- ointment 0.1 %
- implant 1.35 mg
Cautions
- Growth rate of some children may be slower during use
Pregnancy Undefined
Lactation Undefined
Cost
Mometasone (NASONEX)
What pharmacies pay · NADAC 9/30/26
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 50 mcg/spray | nasal spray | per unit | $1.59/g | offered |
Generic entry2002
NO BOXED WARNINGS
Principal riskOral candidiasis when inhaled
Classes and tags
Clinical profile
Legacy pregnancy categoryC
Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.